Braxia Scientific Announces Fiscal Q1 2022 Financials: $0.4 Million In Revenue, $1.1 Million Net Loss
Braxia Scientific Corp. (CSE: BRAX) reported on Monday night its financial results for the fiscal first quarter 2022 ending June
Read more
Braxia Scientific
Braxia Scientific Launches Multiple-Dose Psilocybin Clinical Trial for Treatment-Resistant Depression
Braxia Scientific Corp. (CSE: BRAX), formerly Champignon Brands, announced today that its clinical research and development team will start a randomized
Read more
Champignon Brands To Change Name To Braxia Scientific
Champignon Brands (CSE: SHRM) is evidently looking to turn a new leaf, with the company this morning announcing that it
Read more